| Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori AC Wotherspoon, TC Diss, L Pan, PG Isaacson, C Doglioni, A Moschini, ... The Lancet 342 (8871), 575-577, 1993 | 2770 | 1993 |
| Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma AC Wotherspoon, C Ortiz-Hidalgo, MR Falzon, PG Isaacson The Lancet 338 (8776), 1175-1176, 1991 | 2524 | 1991 |
| Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label … T Waddell, I Chau, D Cunningham, D Gonzalez, AFC Okines, ... The lancet oncology 14 (6), 481-489, 2013 | 868 | 2013 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 599 | 2018 |
| Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging–defined poor-risk rectal cancer I Chau, G Brown, D Cunningham, D Tait, A Wotherspoon, AR Norman, ... Journal of Clinical Oncology 24 (4), 668-674, 2006 | 568 | 2006 |
| Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial EC Smyth, A Wotherspoon, C Peckitt, D Gonzalez, S Hulkki-Wilson, ... JAMA oncology 3 (9), 1197-1203, 2017 | 557 | 2017 |
| Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total … A Dewdney, D Cunningham, J Tabernero, J Capdevila, B Glimelius, ... Journal of Clinical Oncology 30 (14), 1620-1627, 2012 | 465 | 2012 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 464 | 2017 |
| Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer F Pietrantonio, R Miceli, A Raimondi, YW Kim, WK Kang, RE Langley, ... Journal of Clinical Oncology 37 (35), 3392-3400, 2019 | 448 | 2019 |
| Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases S Frentzas, E Simoneau, VL Bridgeman, PB Vermeulen, S Foo, ... Nature medicine 22 (11), 1294-1302, 2016 | 446 | 2016 |
| EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT A Ruskoné-Fourmestraux, W Fischbach, BMP Aleman, H Boot, MQ Du, ... Gut 60 (6), 747-758, 2011 | 437 | 2011 |
| Variable frequencies of t (11; 18)(q21; q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma H Ye, H Liu, A Attygalle, AC Wotherspoon, AG Nicholson, F Charlotte, ... Blood 102 (3), 1012-1018, 2003 | 420 | 2003 |
| Programmed death-ligand 1 immunohistochemistry testing: a review of analytical assays and clinical implementation in non–small-cell lung cancer R Büttner, JR Gosney, BG Skov, J Adam, N Motoi, KJ Bloom, M Dietel, ... Journal of Clinical Oncology 35 (34), 3867-3876, 2017 | 410 | 2017 |
| Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial YJ Chua, Y Barbachano, D Cunningham, JR Oates, G Brown, ... The lancet oncology 11 (3), 241-248, 2010 | 400 | 2010 |
| High incidence of primary gastric lymphoma in northeastern Italy C Doglioni, A Moschini, M de Boni, AC Wotherspoon, PG Isaacson The Lancet 339 (8797), 834-835, 1992 | 399 | 1992 |
| ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma M Dreyling, C Thieblemont, A Gallamini, L Arcaini, E Campo, O Hermine, ... Annals of Oncology 24 (4), 857-877, 2013 | 367 | 2013 |
| Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue AC Wotherspoon, TM Finn, PG Isaacson Blood 85 (8), 2000-2004, 1995 | 363 | 1995 |
| Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, ... Leukemia 22 (3), 487-495, 2008 | 323 | 2008 |
| Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up✰ E Zucca, L Arcaini, C Buske, PW Johnson, M Ponzoni, M Raderer, ... Annals of oncology 31 (1), 17-29, 2020 | 317 | 2020 |
| CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment PEM Patten, AGS Buggins, J Richards, A Wotherspoon, J Salisbury, ... Blood, The Journal of the American Society of Hematology 111 (10), 5173-5181, 2008 | 317 | 2008 |
